---
title: "US FDA clears TELLTALE TAVI guidewire system"
date: "2025-11-25T11:10:16.000Z"
publishedDate: "25 novembre 2025"
summary: "Transmural Systems has obtained 510(k) clearance from the US Food and Drug Administration (FDA) for TELLTALE a dedicated electrosurgical guidewire system to prevent coronary obstruction in patients undergoing transcatheter aortic valve implantation (TAVI) for both native aortic stenosis and bioprosthetic valve failure. FDA clearance for TELLTALE was granted after a comprehensive pivotal study highlighting the [&#8230;] The post US FDA clears TELLTALE TAVI guidewire system appeared first on Cardiovascular News ."
importance: ""
sourceUrl: "https://cardiovascularnews.com/us-fda-clears-telltale-tavi-guidewire-system/"
tags: ["France", "Actualité", "Cardiovascular News — Latest"]
permalink: "/papers/2025-11-25-us-fda-clears-telltale-tavi-guidewire-system"
imageUrl: "http://cardiovascularnews.com/wp-content/uploads/sites/14/2023/03/TAVI-2.1.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/us-fda-clears-telltale-tavi-guidewire-system/"
---

![US FDA clears TELLTALE TAVI guidewire system](http://cardiovascularnews.com/wp-content/uploads/sites/14/2023/03/TAVI-2.1.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/us-fda-clears-telltale-tavi-guidewire-system/*

## L’essentiel

Transmural Systems has obtained 510(k) clearance from the US Food and Drug Administration (FDA) for TELLTALE a dedicated electrosurgical guidewire system to prevent coronary obstruction in patients undergoing transcatheter aortic valve implantation (TAVI) for both native aortic stenosis and bioprosthetic valve failure. FDA clearance for TELLTALE was granted after a comprehensive pivotal study highlighting the [&#8230;] The post US FDA clears TELLTALE TAVI guidewire system appeared first on Cardiovascular News .

## Lien source

https://cardiovascularnews.com/us-fda-clears-telltale-tavi-guidewire-system/
